ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2982

Blood Perfusion in Different Skin Areas of Hands in Primary Raynaud’s Phenomenon and Systemic Sclerosis Patients

Alberto Sulli1, Barbara Ruaro1, Amelia Chiara Trombetta1, Vanessa Smith2, Carmen Pizzorni1, Sabrina Paolino1 and Maurizio Cutolo1, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS A.O.U. San Martino-IST, University of Genova, Genoa, Italy, Genoa, Italy, 2Department of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: capillaroscopy and systemic sclerosis, Raynaud's phenomenon

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Peripheral blood perfusion is reduced in patients affected by both primary (PRP) or secondary Raynaud’s phenomenon (SRP) (1-2). The objective of this study was to investigate blood perfusion (BP) in different skin areas of patients with PRP, SRP to systemic sclerosis (SSc), and healthy subjects (CNT), looking for differences between the groups.

Methods: Seventy SSc patients (new ACR/EULAR criteria) (3) (mean age 63±12 years, mean disease duration 6±5 years), 31 PRP patients (LeRoy criteria) (4) (mean age 48±18 years, mean Raynaud duration 3±2 years) and 68 CNT (mean age 59±19 years) were enrolled during winter time, after informed consent. BP was assessed by Laser speckle contrast analysis (LASCA) at the level of fingertips, periungual areas, dorsal and palmar aspect of 3rd finger bilaterally, dorsum and palm of both hands, and the average BP calculated as perfusion units (PU) (1). Nailfold videocapillaroscopy (NVC) was also performed to distinguish between PRP and SRP, and to detect the proper pattern of nailfold microangiopathy (“early”, “active” or “late”) (5). Patients were not taking vasodilator drug since al least two weeks.

Results: Both PRP and SSc patients showed a statistically significant lower BP than CNT at the level of fingertips (median 86, 88, 186 PU, respectively, p<0.0001), periungual (median 75, 76, 142 PU, respectively, p<0.0001), palmar aspect of 3rd finger (median 71, 81, 134 PU, respectively, p<0.0001), and palm areas (median 61, 78, 112 PU, respectively, p<0.0001). On the contrary, the three groups displayed similar BP values at the level of other areas of hands. Of interest, PRP patients showed lower BP values than SSc patients in all areas of hand, even if BP was found statistically different only at the level of both palmar aspects of 3rd finger (p=0.04) and palm of hands (p=0.008). The gradients of BP fingertip-phalanx-palm and periungual-phalanx-dorsum were significantly lower in PRP than in SSc patients (p<0.0001), as well as significantly higher in CNT when compared with both PRP and SSc patients (p<0.0001). A statistically significant progressive decrease of BP was observed in SSc patients with progressive pattern of nailfold microangiopathy (“early”, “active”, and “late”) at the level of fingertips, periungual, palmar aspect of 3rd fingers and palm areas (p<0.05). Moreover, BP was significantly lower in PRP than in SSc patients with the “early” pattern of microangiopathy in all areas  (p<0.04), with the exception of dorsal phalanx and hand dorsum.

Conclusion: By considering a small cohort of patients, BP of hand was found lower in PRP than in SSc patients with the “early” NVC pattern of microangiopathy. Also the gradients of perfusion between distal and proximal areas of hand were significantly lower in PRP than in SSc patients. The clinical value of this new early finding is matter of further analysis.

References: 1. Ruaro B, et al. Ann Rheum Dis 2014;73:1181-5.  2. Rosato E, et al. Rheumatology 2009;36:2257-63.  3. van den Hoogen F, et al. Ann Rheum Dis 2013; 72:1747-55.   4. LeRoy EC, et al. Clin Exp Rheumatol.1992;10:485-8.  5. Sulli A, et al. Arthritis Rheum. 2012;64:821-5.


Disclosure: A. Sulli, None; B. Ruaro, None; A. C. Trombetta, None; V. Smith, None; C. Pizzorni, None; S. Paolino, None; M. Cutolo, None.

To cite this abstract in AMA style:

Sulli A, Ruaro B, Trombetta AC, Smith V, Pizzorni C, Paolino S, Cutolo M. Blood Perfusion in Different Skin Areas of Hands in Primary Raynaud’s Phenomenon and Systemic Sclerosis Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/blood-perfusion-in-different-skin-areas-of-hands-in-primary-raynauds-phenomenon-and-systemic-sclerosis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/blood-perfusion-in-different-skin-areas-of-hands-in-primary-raynauds-phenomenon-and-systemic-sclerosis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology